Pharmaceutical Contract Manufacturing. Technology Transfer

This section is devoted to the Contract Manufacturing of Pharmaceuticals at the facilities of independent producers, who are fully compliant with technological processes and Quality Control in accordance with client requirements

Types of Contractors

  • Manufacturers, who specialize only in Contract Manufacturing
  • Manufacturers, who produce their own brands along with Contract Manufacturing

Types of Contract Services

  • Full-cycle manufacturing
  • Performing only some of the manufacturing operations (ex. packaging)
pharma-control

Twelve production lines will be constructed in Moscow

The second offset contract for the supply of medicines will be concluded with LLC R-Opra, providing for the reciprocal investment obligations of the supplier-investor.
manufacturing

Singapore company RV Healthcare intends to localize in Uzbekistan

First Deputy Chairman of the State Committee of the Republic of Uzbekistan for Investments, Sunatulla Bekenov, held a meeting with representatives of the Singapore company RV HEALTHCARE PTE. LTD.
scientist

Canon Medical establishes a joint company with ACT Genomics

Canon Medical System Corporation completed the acquisition of the majority shares of ACTmed, a joint venture company established with ACT Genomics, a Taiwanese molecular diagnostic company.
nacimbio

Nacimbio completed Phase I clinical trials of the rotavirus vaccine

Nacimbio has completed the first phase of clinical trials of the rotavirus vaccine. The new drug will be packaged in Russia in 2020 already, while the full production cycle will be launched in 2026.
pharmstandard

Gilead localizes the production of hepatitis C and HIV drugs in Russia

According to the agreement Pharmstandard production facilities will manufacture Sovaldi® for the treatment of chronic hepatitis C and Truvada® for the treatment of HIV.
stem cells

Takara Bio receives a manufacturing license from Swedish Medical Product Agency

Takara Bio announced that the Medical Products Agency granted a manufacturing license for derivation and banking of human embryonic stem (hES) cells to be produced under GMP conditions.
takeda

Takeda launches production of the Ixazomib in Yaroslavl

The global pharmaceutical company Takeda announces the opening of a production site at its plant in Yaroslavl for manufacturing Ixazomib, an innovative drug for patients with multiple myeloma.
pik-pharma

PIK-PHARMA localized full-cycle manufacturing of Magnerot

PIK-PHARMA has successfully localized full-cycle manufacturing of Magnerot, a popular drug of WÖRWAG Pharma GmbH from Germany, at the facilities of PIK-PHARMA LEK site.
stem cells

Israeli biotech receives financing to develop precision-medicine technology

NewStem, a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness, announced a $4 million financing.

Actual

Contact Manufacturing Companies